Novel biomarkers related to oxidative stress and immunity in chronic kidney disease

Fang Bai1,2, Chunjie Wang1,2, Xin Fan1

  • 1Department of Nephrology, Qilu Hospital of Shandong University, Jinan, 250012, Shandong, China.

Heliyon
|March 22, 2024
PubMed
Abstract

Insights

This study identifies NCF2, S100A9, and SELL as key genes involved in immune response and oxidative stress in chronic kidney disease (CKD). These genes show potential as novel biomarkers for CKD diagnosis and treatment.

Area of Science:

  • Nephrology
  • Genomics
  • Immunology

Background:

  • Chronic kidney disease (CKD) incidence is rising globally, necessitating new diagnostic and therapeutic strategies.
  • Limited treatment options highlight the urgent need for novel molecular targets in CKD management.

Purpose of the Study:

  • To identify novel diagnostic biomarkers for chronic kidney disease (CKD).
  • To investigate the role of immune-related oxidative stress genes in CKD pathogenesis.
  • To validate potential hub genes as diagnostic markers for CKD.

Main Methods:

  • Bioinformatic analysis of Gene Expression Omnibus (GEO) data to identify differentially expressed genes (DEGs).
  • Integration of oxidative stress gene data, immune infiltration analysis, Weighted Gene Co-expression Network Analysis (WGCNA), and Protein-Protein Interaction (PPI) network analysis.
  • Validation using external datasets, animal models (5/6 nephrectomy), and clinical correlation analysis (Nephroseq v5).

Main Results:

  • Identification of 29 differentially expressed immune-related oxidative stress genes (DEIOSGs) in CKD.
  • NCF2, S100A9, and SELL were identified as hub genes through PPI analysis.
  • Hub genes showed significant upregulation in CKD, excellent diagnostic efficacy (ROC analysis), and correlated with renal function decline.

Conclusions:

  • NCF2, S100A9, and SELL are validated as diagnostic biomarkers for CKD.
  • These hub genes are linked to immune response and oxidative stress pathways in CKD.
  • The identified biomarkers offer potential for advancing CKD diagnosis and therapeutic strategies.